Moderna’s COVID-19 vaccine more than doubled the level of antibodies compared to the Pfizer vaccine, according to a study of healthcare workers in Belgium, researchers found. A research letter published in JAMA drew from 2,499 healthcare workers who received two doses of either the Pfizer/BioNTech vaccine or Moderna’s shot.